Drug
Liquid Alpha1 Proteinase Inhibitor
Liquid Alpha1 Proteinase Inhibitor: highest development phase Phase 2, developed by Grifols. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Grifols
Trials
| Drug | Phase | Indication |
|---|---|---|
| Liquid Alpha1-Proteinase Inhibitor (Human) NCT04547140 | Phase 2 | COVID-19 |
Latest
No recent events.
Follow Liquid Alpha1 Proteinase Inhibitor on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.